Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath sampler and collection kit. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Orlando, Florida.
Metrics to compare | GIPL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGIPLPeersSector | |
---|---|---|---|---|
P/E Ratio | −14.2x | −3.9x | −0.5x | |
PEG Ratio | −0.53 | −0.07 | 0.00 | |
Price/Book | 30.8x | 2.2x | 2.6x | |
Price / LTM Sales | - | 2.3x | 3.2x | |
Upside (Analyst Target) | - | 89.1% | 45.7% | |
Fair Value Upside | Unlock | −14.9% | 8.6% | Unlock |